Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
-
Groupe Casino: Changes in governance at Monoprix and Naturalia
-
Share buybacks in Spar Nord Bank – transactions in week 38
-
Second Well Delineates Heisenberg, Confirms Size of Discovery
-
Terranet reaches strategic milestone - achieves autonomous braking
-
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
-
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
-
Litchfield Hills Research raises its buy recommendation for Virtualware to €12 per share
-
Equinor ASA: Share buy-back
-
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy
-
TRiCares Announces First Topaz Implantation in EU Pivotal Study
-
Financing Update – Important clarification
-
Progress on share buyback programme
-
Soitec: Soitec and Resonac announce the signing of a joint development agreement in SmartSiC™ to accelerate high-performance silicon carbide adoption in next-generation electric vehicles
-
Lleida.net covers 100% of its newest private purchase plan, in a transaction of more than 225,000 euros
-
Transaction in Own Shares
-
Haffner Energy teams up with Bambbco, France’s leading bamboo provider, to diversify sustainable biomass procurement
-
Sampo plc’s share buybacks 23 September 2024
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis
-
Belships ASA: Key information relating to the cash dividend to be paid by Belships ASA
-
Nature Reviews Highlights Significant Successes of Antibiotic Collaboration and Calls for Sustainable R&D Funding Schemes
-
UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024
-
Start of Day Message
-
Belships ASA: Extraordinary dividend payment
-
Santhera Announces Acceptance by Swissmedic of Marketing Authorization Application for AGAMREE® (vamorolone) in Duchenne Muscular Dystrophy
-
ABC arbitrage: HY 2024 Results
-
Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses
-
EfTEN REAL ESTATE FUND AS NOTICE CALLING THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
-
Chinese folk music from Jiangsu radiates along Rhein
-
Georgia College & State University jumps to No. 4 “Most Innovative School” in U.S. News & World Report's 2025 Best Colleges
-
Georgia College & State University jumps to No. 4 “Most Innovative School” in U.S. News & World Report's 2025 Best Colleges
-
U.S. News ranks USF a top 50 public university for the sixth consecutive year and as the best value among all Florida universities
-
Griffin Global Asset Management Announces Closing of $400 Million Senior Unsecured Notes Offering
-
Duolingo Introduces AI-Powered Innovations at Duocon 2024
-
Schweiter Technologies Innovation & Capital Markets Day 2024
-
BTCC Exchange Kicks Off Global Ambassador Program Offering Exciting Incentives
-
Hitachi Rail Unveils the ‘HMAX’ AI Solution, Accelerated by NVIDIA, to Optimize Trains, Signaling and Infrastructure
-
Dundee Corporation Announces Acquisition of Shares of Maritime Resources Corp.
-
BioVie Inc. Announces Pricing of Public Offering
-
Sibros and FutureMotiv Announce Strategic Partnership to Deliver Integrated Software-Defined Vehicle Solutions
-
Arllecta Group announces its new S2S algorithm that significantly outperforms current strong GPT-solutions
-
Nova Minerals Limited Announces Pricing of Public Offering
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time
-
Tectum Launches the Tectum Light Node for Custom Token Development
-
URZ3 Energy Announces Passing of Director Benjamin D. Leboe
-
Calm Waters Partnership Acquires Common Shares of Fiddlehead Resources Corp.
